| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/1998 | WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | WO1998007737A1 Method for determining expression of aberrant forms of apc protein |
| 02/26/1998 | WO1998007736A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | WO1998007735A1 Pancreas-derived plasminogen activator inhibitor |
| 02/26/1998 | WO1998007441A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 02/26/1998 | WO1998007440A1 A novel antimicrobial peptide isolated from bufo bufo gargarizans |
| 02/26/1998 | WO1998007320A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM) |
| 02/26/1998 | WO1998003669A3 Vectors for inhibiting hiv and tumor growth |
| 02/26/1998 | WO1998003652A3 P300/cbp-associated transcriptional co-factor p/caf and uses thereof |
| 02/26/1998 | WO1998003200A3 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 02/26/1998 | WO1998002546A3 Dna immunization against chlamydia infection |
| 02/26/1998 | WO1998002534A3 Transgenic animal whose expression of the opiate receptors is modified |
| 02/26/1998 | WO1998002453A3 Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
| 02/26/1998 | WO1998001570A3 Mutated antibody-dependent infection enhancing domains of hiv |
| 02/26/1998 | WO1997049807A3 A novel hypertension related calcium regulated gene (hcarg) |
| 02/26/1998 | WO1997049373A3 Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin |
| 02/26/1998 | WO1997046681A3 Galanin receptor galr2 |
| 02/26/1998 | WO1997039123A3 Secreted proteins |
| 02/26/1998 | WO1997029199A3 Prostate specific antigen peptides and uses thereof |
| 02/26/1998 | DE19732135A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 02/26/1998 | DE19649207C1 Nucleic acid characteristic of late or early passage cells immortalised by papilloma virus |
| 02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
| 02/26/1998 | CA2269654A1 Long-term expression of gene products by transforming muscle cells |
| 02/26/1998 | CA2264271A1 Transformed wheat having improved breadmaking characteristics |
| 02/26/1998 | CA2264203A1 Compositions and methods for use of defensin |
| 02/26/1998 | CA2264200A1 Human endokine alpha |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2264054A1 Method for determining expression of aberrant forms of apc protein |
| 02/26/1998 | CA2263942A1 Novel osteopontin derived chemotactic peptides and methods of use |
| 02/26/1998 | CA2263894A1 Novel human growth factors |
| 02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | CA2263875A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263871A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | CA2263838A1 Crystal structures of a protein tyrosine kinase |
| 02/26/1998 | CA2263832A1 T1 receptor-like ligand ii |
| 02/26/1998 | CA2263830A1 T1 receptor-like ligand i |
| 02/26/1998 | CA2263803A1 E2f ubiquitination domain, and assays for inhibitors of e2f ubiquitination |
| 02/26/1998 | CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 02/26/1998 | CA2263744A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263189A1 A short-shafted adenoviral fiber and its use |
| 02/26/1998 | CA2263141A1 Neutralization-sensitive epitopes of cryptosporidium parvum |
| 02/26/1998 | CA2263140A1 Targeting adenovirus with use of constrained peptide motifs |
| 02/26/1998 | CA2235148A1 Novel dnas and process for producing proteins by using the same |
| 02/25/1998 | EP0825442A2 Morphogenic protein screening method |
| 02/25/1998 | EP0825262A2 Tissue-specific toxin expression in plants |
| 02/25/1998 | EP0825257A2 Protein involved in regenerating luciferin |
| 02/25/1998 | EP0825198A1 Plag gene family and tumorigenesis |
| 02/25/1998 | EP0825194A2 An amide derivative of amythiamicin |
| 02/25/1998 | EP0824700A1 Method of diagnosing prostate cancer |
| 02/25/1998 | EP0824699A2 Compounds and methods for diagnosis of leishmaniasis |
| 02/25/1998 | EP0824593A2 Engineering protein posttranslational modification in transgenic organisms |
| 02/25/1998 | EP0824590A1 Vasoactive intestinal peptide |
| 02/25/1998 | EP0824589A1 Utrophin gene promoter |
| 02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
| 02/25/1998 | EP0824587A2 Method for activating a reversibly inactivated immobilized enzyme by release from an immobilising moiety and its use in nucleicacid amplification reactions |
| 02/25/1998 | EP0824548A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits |
| 02/25/1998 | EP0824547A1 Anti-fungal peptides |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824545A1 Peptide compositions with growth factor-like activity |
| 02/25/1998 | EP0824361A1 Stable virus packaging cell lines |
| 02/25/1998 | EP0824360A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
| 02/25/1998 | EP0824359A1 Peptide-based vaccine against papillomavirus infection |
| 02/25/1998 | EP0824358A1 Acellular pertussis vaccines and methods of preparation thereof |
| 02/25/1998 | EP0824352A1 Cyclodextrin compounds and methods of making and use thereof |
| 02/25/1998 | EP0711304B1 Nickel-free hemoglobin and methods for producing such hemoglobin |
| 02/25/1998 | EP0652227B1 Method of purifying hydrophobic polypeptide |
| 02/25/1998 | EP0563222B1 Biologically active bactericidal/permeability-increasing protein fragments |
| 02/25/1998 | EP0500695B1 GnRH ANALOGS |
| 02/25/1998 | CN1174573A Human vascular IBP-like growth factor |
| 02/25/1998 | CN1174572A Human tissue inhibitor of metalloproteinase -4 |
| 02/25/1998 | CN1174559A Major outer membrane protein CD of Moraxella |
| 02/25/1998 | CN1174558A Tumor necrosis factor-Gamma |
| 02/25/1998 | CN1174509A Gene transfer-mediated angiogenesis therapy |
| 02/24/1998 | US5721367 Homologous recombination in mammalian cells |
| 02/24/1998 | US5721354 For treatment of infections, medical diagnosis |
| 02/24/1998 | US5721353 DNAs coding for LCU13 ! motilin |
| 02/24/1998 | US5721352 Entomopoxvirus expression system |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721349 Genetically altered mutant strain |
| 02/24/1998 | US5721348 DNA encoding PH-20 proteins |
| 02/24/1998 | US5721342 Glycosylated protein isolated from milk |
| 02/24/1998 | US5721340 p53 proteins with altered tetramerization domains |
| 02/24/1998 | US5721337 Human thymosin β15 |
| 02/24/1998 | US5721213 Peptides, active as inhibitors of platelet aggregation |
| 02/24/1998 | US5721212 Peptides for heparin and low molecular weight heparin anticoagulation reversal |
| 02/24/1998 | US5721210 Cyclic cell adhesion modulation compounds |
| 02/24/1998 | US5721207 Administering elcatonin in acceptable vehicle by intrathecal route |
| 02/24/1998 | US5721137 Stable synthetic promoter which controlls expression of a heterologous gene in escherichia and bacillus |
| 02/24/1998 | US5721133 Hybrid regulatory proteins which contain amino acid sequences that are susceptible to cleavage by specific proteolytic enzymes; alters rate of production of products of indicator genes |
| 02/24/1998 | US5721132 Synthetic gene for D4 dopamine receptors |
| 02/24/1998 | US5721130 Monitoring alzheimer's disease |
| 02/24/1998 | US5721122 Obtaining lymphocytes |
| 02/24/1998 | US5721121 Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein |
| 02/24/1998 | US5721119 Nucleic acid sequences |
| 02/24/1998 | US5721115 Genetic engineering |
| 02/24/1998 | US5721114 Cultivating a transformed escherichia strain in culture medium, inducing expression of apolipoprotein a1-m protein of specific amino acid sequence in logarithmic growth phase before stationary phase is attained, separating the product |
| 02/24/1998 | US5721113 Polynucleotide encoding new ets-related factor 1 |